NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 18, 2024 $51.57 +4.02% $49.11 X 94.99% 0
Nov 18, 2024 $50.83 +2.51% $49.11 X 96.51% 0
Nov 18, 2024 $95.00 +91.61% $49.11 X 6.56% 0
Nov 1, 2024 $74.31 +2.44% $72.88 V 98.04% 1
Nov 1, 2024 $71.43 -1.53% $72.88 X 98.02% 0
thedean2010 thedean2010 Merchant
Nov 1, 2024 Bullish $72.88 V 1
Oct 16, 2024 $63.89 -2.27% $65.85 X 97.03% 0
Oct 16, 2024 $64.45 -1.42% $65.85 X 97.88% 0
Oct 16, 2024 Bearish $65.85 X 0
Oct 4, 2024 $63.16 -1.48% $64.96 X 97.23% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE